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INTRODUCTION
The GZP6 high dose rate (HDR) afterloading brachytherapy unit (Nuclear 
Power Institute of China) (1) has recently been introduced in the Iranian 
radiation oncology centers. The unit has six different cobalt-60 source 
braids being loaded in tandem and ovoid applicators. The sources are used 
in the treatment of cervix, vagina, rectum, esophagus, and a number of 
other cancers. The unit has a treatment planning system, which presents 
dose distributions for different insertions in terms of isodose curves (2).
In dose delivery by brachytherapy systems, the delivered dose to the 
target volume and the dose received by the adjacent critical organs are 
calculated using dose distributions presented by treatment planning sys-
tem (3). The treatment planning systems commonly calculate the dose 
distributions by assuming each source as a point source. The source 
capsule, inter-pellet attenuation, and scattering are not also incorporated 
in the algorithms used in the treatment planning system for dose calcula-
tions (4). Since the treatment planning systems use simplified algorithms 
in their dose calculations, verification of the dose distributions presented 
by the systems may be of clinical importance (5). Evaluation of the treat-
ment planning systems in terms of their presented dose distribution can 
be a part of quality assurance in the clinical practice of brachytherapy (6).
There are scarce studies conducted on GZP6 unit focusing on the calcula-
tion and measurement of task group number 43 (TG-43) (7) parameters 
for different sources of the GZP6 unit (8, 9). In our previous study, an 
evaluation verifying the dose distribution around the first source of GZP6 
unit was performed (10). Naseri et al. have studied dose distribution 
around the source number one, two, and five of the unit but their study 
was for a vaginal applicator and was based on relative dose evaluations 
(2). To our knowledge there is no other study verifying dose distributions 
around source braids of this unit. In this study, the dose distributions 
presented by GZP6 treatment planning system for the source braids No. 
2 and No. 5 were evaluated based on Monte Carlo simulations and in-
phantom radiochromic film measurements.
MATERIALS AND METHODS
GZP6 sources and GZP6 straight tandem applicator
GZP6 afterloading HDR unit has 6 sources. The sources 1 to 5 are non-
stepping and the source 6 is a stepping source. In this study, we evaluated 
the sources number two and five of the unit. The source braids No. 2 and 
5 contain respectively four and three active cylindrical cobalt-60 pellets 
(with a radius of 0.5 mm and length of 2 mm). A number of non-active 
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SUMMARY
Background:  Treatment planning systems (TPSs) are used for dose calculations in dose delivery by afterload-
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plane.
Conclusion: The results showed that dose distributions certified by the GZP6 TPS for the GZP6 source No. 2 were 
validated. However, for source No. 5 some discrepancies were observed. Accurate knowledge of the activity of each 
active pellet in the source No. 5 can clarify the cause of the discrepancies.
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In-phantom measurements
The measurements were performed in a 50×50×50 cm
3 Perspex phantom 
containing 1 cm Perspex slabs. A hole was drilled in between two slabs 
to house the applicator. The radiochromic film was inserted between the 
Perspex slabs in such a way that the dose can be measured in a longitu-
dinal plane relative to the long axis of the applicator.
The measurement set-up including the GZP6 afterloading unit and the 
Perspex phantom is shown in Figure 3. 
Figure 3. In phantom measurement set-up showing the GZP6 afterloading unit and 
the perspex phantom
Film scanning
A Microtek color scanner (model: ScanMaker Pro 1000XL, Microtek 
International Inc., Hsinchu, Taiwan) was used for film digitization. The 
films were scanned 24 hours after irradiation. The films were positioned 
in the central portion of the scanning bed in the landscape direction. Each 
film, calibration and measurement films, was scanned 3 times to over-
come the scanner noise effects. Scanning was performed three times for 
each piece of film with 100 ppi (points per inches) resolution and 48-bit 
RGB color mode. The film images were saved as unzipped TIFF format 
files. Averaged image between three scans for each film was used for 
the purpose of noise reduction. The red color channel was used for the 
extraction of optical density values. The net optical density was calculated 
as the difference of the optical density for each film pixel before and after 
the film irradiation. The room temperature during the film calibration, 
measurement, and reading was as normal room temperature to avoid 
the effect of film heating in the measurement of optical density. The net 
optical density was plotted versus the delivered dose for the calibration 
films and the fitted curve was used in the reading of measurement film for 
conversion of net optical value to the dose value. The detailed scanning 
procedure is the same as that used in our previous study (13). 
GZP6 treatment planning system
The GZP6 treatment planning system presents two dimensional dose 
distributions for six GZP6 sources as well as a number of source combi-
nations. It uses Sievert integral for calculation of dose distributions. The 
GZP6 treatment planning system is able to produce dose distributions in 
the transverse and longitudinal planes.
Dose distribution comparisons 
Dose distributions obtained by the MC, RCF and TPS were compared. For 
this purpose, the film dosimetry results were considered as reference and the 
results of MC and GZP6 TPS were compared with the film dosimetry results. 
Comparisons were based on one dimensional gamma function calculations. 
Specially written software named gamma_index.exe by DOSISoft Company 
was provided. The software is working in the environment of Gnuplot soft-
ware (version 4.4 patch level 3, Geeknet Inc., USA). As recommended by 
IAEA TRS 430 report for commissioning of brachytherapy treatment planning 
system (17), a 5% dose/2 mm distance criterion was established for our 
gamma index calculations. 
As it will be mentioned in the results section, some discrepancies were 
observed for the source No. 5 between the dose distributions obtained by MC, 
GZP6, and RCF methods. It is believed that the discrepancies may be related to 
the uncertainty of total activity of the source No. 5 or partial activity of each three 
active pellets contained in this source. Two new experiments were arranged on 
the source No. 5 to illuminate the cause of the discrepancies: (1) Estimation of 
air kerma strength by MC and in air measurements since the total activity and 
air kerma strength are dependent; (2) Measurement of the activity of the active 
pellets in this source by placing a radiochromic film under the source braid. Air 
kerma rates for source No. 5 were measured using a Farmer type ionization 
chamber (NE 2581, #1106) following multiple distance method. Air kerma 
strength was then calculated using the measured air kerma rates and the result 
was compared by the value of air kerma strength obtained by MC simulations 
and that ascertained by the GZP6 TPS. The details for air kerma strength estima-
tions in this study were as described in our previous study for the GZP6 source 
No. 3 (10). As it has already been mentioned the activities of active pellets in the 
source was measured by placing a sheet of radiochromic film under the source. 
The sheet was selected from the same batch used in our radiochromic film 
calibration and in phantom measurements in this study and the calibration fitting 
was used to convert net optical density map to dose map for the sheet of film.
RESULTS AND DISCUSSION
The isodose curves obtained through Monte Carlo simulation and those 
presented by the GZP6 treatment planning system in the transverse plane 
relative to the applicator long axis for the GZP6 sources No. 2 and 5 are 
contoured in Figure 4. The contours of 1.25, 2.5, 3.75, 5, 6.25, and 7.5 
Gy are plotted in the Figure 4.
Figure 4. Isodose curves in the transverse plane obtained through Monte Carlo simulations (blue lines) and GZP6 
treatment planning system (color lines): parts (a) and (b) are related to the GZP6 source braids number 2 and 5 
respectively. The dose contours of 1.25-7.5 Gy are illustrated from the peripheral to central region in the figure
spherical pellets (with radius of 1.5 mm) exist in the source braids and 
are as intervals between the active ones (Figure 1). Each active pellet has 
a thin nickel platting and it is covered by a titanium capsule. The active 
and non-active pellets are covered by a spring cover.
Figure 1. A schematic figure illustrating the GZP6 source braid number two (a) and five (b). The source braids consist 
of a number of active 
60Co pellets, non-active spherical stainless steel pellets, and spring cover
The UT0 tandem applicator is a hollow cylindrical with an inner diameter 
of 4.3 mm and wall thickness of 0.6 mm. The applicator was chemically 
analyzed by Esfahan Steel Company and the announced composition was 
incorporated in our Monte Carlo simulations. As the results of the chemi-
cal analysis the main components were: Fe (71.99%), Cr (17.00%), Ni 
(8.22%), Mn (1.37%), Si (0.72%), Ti (0.42%), Mo (0.13%), V (0.06%), C 
(0.05%), P (0.025%), S (0.011%). In this study, the source braids were 
inserted in the tandem applicator in our Monte Carlo simulations and in-
phantom measurements.
Monte Carlo simulations
The MCNPX Monte Carlo code (11) was used as the tool for the simula-
tion of the source braid and the tandem applicator. The source braid, when 
being inside the straight tandem applicator, was centered in a cylindrical 
Perspex phantom with a 25 cm radius and length of 50 cm. The phantom 
was also located in a 1.5 m air filled sphere, simulating the air content. 
Two transverse and longitudinal meshes were overlaid on the geometry to 
obtain dose distributions in the transverse and longitudinal planes relative 
to the applicator respectively. To be consistent with the GZP6 TPS dose 
distribution, the transverse mesh was crossing the point 0, 0, -2.45 cm 
and 0, 0, -1.8 from the origin of the x-y-z coordination respectively for the 
sources No. 2 and 5 (on the center of the first active pellet (Figure 1)). The 
pedep mesh tally type 1 in the MCNPX code was used for photons, giving 
the energy deposition in terms of photon MeV/cm
3 ⋅ . The pedep 
mesh tally was used to score the dose in terms of MeV/cm
3.particle. The 
tally values can be converted to dose in Gy by applying the appropriate 
conversion factors like the source activity, source decay factor, mass 
density etc. (12). The number of source particle histories followed in 
the code was equal to 0.5×10
9. The resulted value of the mean error 
was 1.66 and 1.87% in the mesh cells in the transverse and longitudinal 
directions for source No.2. The obtained statistical errors for source No 
5 in the transverse and longitudinal directions were obtained 1.63, and 
1.86% respectively. More details on the simulation were the same as our 
previous study on the GZP6 source number one (13).
Radiochromic film measurements
Film calibrations
GafChromic EBT radiochromic film sheets (lot number 34351-05, ISP 
Corp., Wayne, NJ, USA (14)) from a single batch were used for calibra-
tion and in phantom measurements. For the purpose of calibration, the 
film pieces of 2×3 cm
2 size were used. Film calibration was performed 
in a 32×32×31 cm
3 water phantom in a 20×20 cm
2 field of a Theratron 
780C Cobalt unit at the depth of 5 cm. Prior to film calibration the output 
of the unit was calibrated using a Farmer type 2581 ionization chamber. 
The film pieces were irradiated in the dose range of 0.5-35 Gy. Three 
pieces of films were irradiated in each calibration dose and the average 
pixel value was used in the calculation of optical density. The irradiated 
films were scanned by a Microtek ScanMaker Pro 1000XL color scanner 
(Microtek International Inc., Hsinchu, Taiwan (15)) 24 hours after the 
film irradiation. The characteristics of the scanner as a radiochromic film 
reader were evaluated in our previous work (13). An image of the Microtek 
1000XL scanner is illustrated in Figure 2.
Figure 2. The Microtek 1000XL scanner used in this study for RCF readings
The net optical density (the difference of the average optical densities on 
irradiated and non irradiated films) was plotted versus the dose and the 
fitted formula was used for further extraction of dose from the net optical 
density in the measurement films. The film handling, scanning protocol 
was according to the recommendations of task group 55 (TG-55) of the 
American Association of Physicists in Medicine (AAPM) report (16).4 5
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to house the applicator. The radiochromic film was inserted between the 
Perspex slabs in such a way that the dose can be measured in a longitu-
dinal plane relative to the long axis of the applicator.
The measurement set-up including the GZP6 afterloading unit and the 
Perspex phantom is shown in Figure 3. 
Figure 3. In phantom measurement set-up showing the GZP6 afterloading unit and 
the perspex phantom
Film scanning
A Microtek color scanner (model: ScanMaker Pro 1000XL, Microtek 
International Inc., Hsinchu, Taiwan) was used for film digitization. The 
films were scanned 24 hours after irradiation. The films were positioned 
in the central portion of the scanning bed in the landscape direction. Each 
film, calibration and measurement films, was scanned 3 times to over-
come the scanner noise effects. Scanning was performed three times for 
each piece of film with 100 ppi (points per inches) resolution and 48-bit 
RGB color mode. The film images were saved as unzipped TIFF format 
files. Averaged image between three scans for each film was used for 
the purpose of noise reduction. The red color channel was used for the 
extraction of optical density values. The net optical density was calculated 
as the difference of the optical density for each film pixel before and after 
the film irradiation. The room temperature during the film calibration, 
measurement, and reading was as normal room temperature to avoid 
the effect of film heating in the measurement of optical density. The net 
optical density was plotted versus the delivered dose for the calibration 
films and the fitted curve was used in the reading of measurement film for 
conversion of net optical value to the dose value. The detailed scanning 
procedure is the same as that used in our previous study (13). 
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The GZP6 treatment planning system presents two dimensional dose 
distributions for six GZP6 sources as well as a number of source combi-
nations. It uses Sievert integral for calculation of dose distributions. The 
GZP6 treatment planning system is able to produce dose distributions in 
the transverse and longitudinal planes.
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Dose distributions obtained by the MC, RCF and TPS were compared. For 
this purpose, the film dosimetry results were considered as reference and the 
results of MC and GZP6 TPS were compared with the film dosimetry results. 
Comparisons were based on one dimensional gamma function calculations. 
Specially written software named gamma_index.exe by DOSISoft Company 
was provided. The software is working in the environment of Gnuplot soft-
ware (version 4.4 patch level 3, Geeknet Inc., USA). As recommended by 
IAEA TRS 430 report for commissioning of brachytherapy treatment planning 
system (17), a 5% dose/2 mm distance criterion was established for our 
gamma index calculations. 
As it will be mentioned in the results section, some discrepancies were 
observed for the source No. 5 between the dose distributions obtained by MC, 
GZP6, and RCF methods. It is believed that the discrepancies may be related to 
the uncertainty of total activity of the source No. 5 or partial activity of each three 
active pellets contained in this source. Two new experiments were arranged on 
the source No. 5 to illuminate the cause of the discrepancies: (1) Estimation of 
air kerma strength by MC and in air measurements since the total activity and 
air kerma strength are dependent; (2) Measurement of the activity of the active 
pellets in this source by placing a radiochromic film under the source braid. Air 
kerma rates for source No. 5 were measured using a Farmer type ionization 
chamber (NE 2581, #1106) following multiple distance method. Air kerma 
strength was then calculated using the measured air kerma rates and the result 
was compared by the value of air kerma strength obtained by MC simulations 
and that ascertained by the GZP6 TPS. The details for air kerma strength estima-
tions in this study were as described in our previous study for the GZP6 source 
No. 3 (10). As it has already been mentioned the activities of active pellets in the 
source was measured by placing a sheet of radiochromic film under the source. 
The sheet was selected from the same batch used in our radiochromic film 
calibration and in phantom measurements in this study and the calibration fitting 
was used to convert net optical density map to dose map for the sheet of film.
RESULTS AND DISCUSSION
The isodose curves obtained through Monte Carlo simulation and those 
presented by the GZP6 treatment planning system in the transverse plane 
relative to the applicator long axis for the GZP6 sources No. 2 and 5 are 
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Gy are plotted in the Figure 4.
Figure 4. Isodose curves in the transverse plane obtained through Monte Carlo simulations (blue lines) and GZP6 
treatment planning system (color lines): parts (a) and (b) are related to the GZP6 source braids number 2 and 5 
respectively. The dose contours of 1.25-7.5 Gy are illustrated from the peripheral to central region in the figure
spherical pellets (with radius of 1.5 mm) exist in the source braids and 
are as intervals between the active ones (Figure 1). Each active pellet has 
a thin nickel platting and it is covered by a titanium capsule. The active 
and non-active pellets are covered by a spring cover.
Figure 1. A schematic figure illustrating the GZP6 source braid number two (a) and five (b). The source braids consist 
of a number of active 
60Co pellets, non-active spherical stainless steel pellets, and spring cover
The UT0 tandem applicator is a hollow cylindrical with an inner diameter 
of 4.3 mm and wall thickness of 0.6 mm. The applicator was chemically 
analyzed by Esfahan Steel Company and the announced composition was 
incorporated in our Monte Carlo simulations. As the results of the chemi-
cal analysis the main components were: Fe (71.99%), Cr (17.00%), Ni 
(8.22%), Mn (1.37%), Si (0.72%), Ti (0.42%), Mo (0.13%), V (0.06%), C 
(0.05%), P (0.025%), S (0.011%). In this study, the source braids were 
inserted in the tandem applicator in our Monte Carlo simulations and in-
phantom measurements.
Monte Carlo simulations
The MCNPX Monte Carlo code (11) was used as the tool for the simula-
tion of the source braid and the tandem applicator. The source braid, when 
being inside the straight tandem applicator, was centered in a cylindrical 
Perspex phantom with a 25 cm radius and length of 50 cm. The phantom 
was also located in a 1.5 m air filled sphere, simulating the air content. 
Two transverse and longitudinal meshes were overlaid on the geometry to 
obtain dose distributions in the transverse and longitudinal planes relative 
to the applicator respectively. To be consistent with the GZP6 TPS dose 
distribution, the transverse mesh was crossing the point 0, 0, -2.45 cm 
and 0, 0, -1.8 from the origin of the x-y-z coordination respectively for the 
sources No. 2 and 5 (on the center of the first active pellet (Figure 1)). The 
pedep mesh tally type 1 in the MCNPX code was used for photons, giving 
the energy deposition in terms of photon MeV/cm
3 ⋅ . The pedep 
mesh tally was used to score the dose in terms of MeV/cm
3.particle. The 
tally values can be converted to dose in Gy by applying the appropriate 
conversion factors like the source activity, source decay factor, mass 
density etc. (12). The number of source particle histories followed in 
the code was equal to 0.5×10
9. The resulted value of the mean error 
was 1.66 and 1.87% in the mesh cells in the transverse and longitudinal 
directions for source No.2. The obtained statistical errors for source No 
5 in the transverse and longitudinal directions were obtained 1.63, and 
1.86% respectively. More details on the simulation were the same as our 
previous study on the GZP6 source number one (13).
Radiochromic film measurements
Film calibrations
GafChromic EBT radiochromic film sheets (lot number 34351-05, ISP 
Corp., Wayne, NJ, USA (14)) from a single batch were used for calibra-
tion and in phantom measurements. For the purpose of calibration, the 
film pieces of 2×3 cm
2 size were used. Film calibration was performed 
in a 32×32×31 cm
3 water phantom in a 20×20 cm
2 field of a Theratron 
780C Cobalt unit at the depth of 5 cm. Prior to film calibration the output 
of the unit was calibrated using a Farmer type 2581 ionization chamber. 
The film pieces were irradiated in the dose range of 0.5-35 Gy. Three 
pieces of films were irradiated in each calibration dose and the average 
pixel value was used in the calculation of optical density. The irradiated 
films were scanned by a Microtek ScanMaker Pro 1000XL color scanner 
(Microtek International Inc., Hsinchu, Taiwan (15)) 24 hours after the 
film irradiation. The characteristics of the scanner as a radiochromic film 
reader were evaluated in our previous work (13). An image of the Microtek 
1000XL scanner is illustrated in Figure 2.
Figure 2. The Microtek 1000XL scanner used in this study for RCF readings
The net optical density (the difference of the average optical densities on 
irradiated and non irradiated films) was plotted versus the dose and the 
fitted formula was used for further extraction of dose from the net optical 
density in the measurement films. The film handling, scanning protocol 
was according to the recommendations of task group 55 (TG-55) of the 
American Association of Physicists in Medicine (AAPM) report (16).6 7
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Figure 7. Dose map under the GZP6 source No. 5 to quantify the activity of each 
active pellet in this source braid
The details are not mentioned here but our results of the radiochromic 
film dosimetry under the source No. 5 showed that the sensitivity and 
accuracy of the experiment was not enough to accurately determine the 
activity of the active pellets in source No. 5.
CONCLUSIONS
The dose distribution in the transverse and longitudinal planes relative 
to the GZP6 source No. two and five when loaded in the GZP6 straight 
tandem applicator presented by the GZP6 treatment planning system was 
verified through Monte Carlo simulations and radiochromic film mea-
surements. Our results show that there are acceptable dose difference 
between the Monte Carlo simulation, radiochromic film measurements, 
and the GZP6 treatment planning dose distributions for source No. two. 
However, the GZP6 treatment planning system presents a simplified dose 
distribution in the regions near the tip and base of the applicator in the 
longitudinal directions for both sources. It can be concluded that the 
GZP6 treatment planning system presents accurate dose distributions in 
both transverse and longitudinal directions from the applicator when is 
used with the source number 2 of the unit. Dose distributions certified 
by the GZP6 TPS for the source No. 5 are not validated thoroughly in all 
points and there are some discrepancies between the results by the three 
mentioned methods for this source. The results of air kerma strength 
and radiochromic film dosimetry for source No. 5 (Table 1 and Figure 
7) indicated that while the total activity for the source used in our Monte 
Carlo calculations was accurate, the main cause of discrepancy between 
dose distribution estimation by MC and RCF dosimetry and GZP6 TPS 
for source No. 5 might be the inaccuracy of activities of active pellets 
in source No. 5 that were certified by GZP6 manufacturer. Therefore, 
accurate knowledge of the activity of each active pellet in source No. 5 
can illuminate the cause of the discrepancies for this source dosimetry.
Acknowledgements
The authors would like to thank Mr. Mojtaba Taheri for his help in in-
phantom measurements, and Reza Radiotherapy and Oncology Center for 
providing the treatment planning data. This work was funded by Sabzevar 
Tarbiat Moallem University and Mashhad University of Medical Sciences. 
Conflict of interest
We declare no conflicts of interest.
REFERENCES
 1 Nuclear Power Institute of China (NPIC), 2010, Available at: www.npic.ac.cn/. 
Accessed October 16, 2011.
 2 Naseri A, Mesbahi A. Application of Monte Carlo calculations for validation of 
a treatment planning system in high dose rate brachytherapy. Rep Pract Oncol 
Radiother. 2009;14:200-4.
 3 Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos 
J, et al; Gynaecological (GYN) GEC-ESTRO Working Group.Recommendations from 
Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D 
image based 3D treatment planning in cervix cancer brachytherapy with emphasis 
on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45. 
 4 Gifford KA, Mourtada F, Cho SH, Lawyer A., Horton JL Jr.. Monte Carlo calcula-
tions of the dose distribution around a commercial gynecologic tandem applicator. 
Radiother Oncol. 2005;77(2):210–5. 
 5 Dogan N, Mihaylov I, Wu Y, Keall PJ, Siebers JV, Hagan MP . Monte Carlo dose 
verification of prostate patients treated with simultaneous integrated boost intensity 
modulated radiation therapy. Radia Oncol. 2009;4:18. 
 6 Buzdar SA, Gadhi MA, Rao MA, Laghari NA, Anees M. Verification of computerized 
treatment planning for HDR 
192Ir Brachytherapy for Gynaecological Cancer. J Pak 
Med Assoc. 2009;59(2):113-5. 
 7 Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry 
of interstitial brachytherapy sources: Recommendations of the AAPM Radiation 
Therapy Committee Task Group No. 43. Med Phys. 1995;22:209-34.
 8 Mesbahi A. Radial dose functions of GZP6 intracavitary brachytherapy 
60Co sources: treat-
ment planning system versus Monte Carlo calculations. Iran J Radiat Res. 2008;5(4):181-6.
 9 Mesbahi A, Naseri A. In-air calibration of new high dose rate 
60Co brachytherapy 
sources: results of measurements on a GZP6 brachytherapy afterloading unit. Rep 
Pract Oncol Radiother. 2008;13(2):69-73.
10  Bahreyni Toossi MT, Ghorbani M, Mowlavi AA, Taheri M, Layegh M, Makhdoumi 
Y, et al. Air kerma strength characterization of a GZP6 Cobalt-60 brachytherapy 
source. Rep Pract Oncol Radiother. 2010;15:190-4.
11  Waters LS. MCNPX User's Manual, Version 2.4.0. Report LA-CP-02-408, Los 
Alamos National Laboratory; 2002.
12  Zhang H, Baker C, Mckinsey R, Meigooni A. Dose verification with Monte Carlo technique 
for prostate brachytherapy implants with 
125I sources. Med Dosimetry. 2005;30(2):85-91. 
13  Bahreyni Toossi MT, Ghorbani M, Mowlavi AA, Bayani Roodi Sh, Haghparast A, 
Meigooni AS. High Dose Rate Brachytherapy Dose Distribution Measurements 
Using EBT Radiochromic Film and a Color Scanner. Great Wall 2010 International 
Congress on Medical Physics, Nanjing, China, 18-22 Aug. 2010.
14  International Specialty Products (ISP), Dosimetry GAFCHROMIC®, [homepage on 
the Internet]. [cited 2010 Oct. 27] Available from: http://online1. ispcorp.com/_lay-
outs/Gafchromic/index.html.
15  Microtek International Inc. Microtek [homepage on the Internet]. [cited 2010 Oct. 
27] Available from: http://www.microtek.com.au/microtek_1000_XL.htm.
16  Niroomand-Rad A, Blackwell CR, Coursey BM, Gall KP , Galvin JM, McLaughlin WL, 
et al. Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy 
Committee Task Group 55. Med Phys. 1998;25:2093–115.
17  Van Dyk J, Rosenwald JC, Fraass B, Cramb J, Ionescu-Farca F, Sharpe MB. IAEA Technical 
Reports Series No. 430: Commissioning and Quality Assurance of Computerized Planning 
Systems for Radiation Treatment of Cancer. Med Phys. 2006;33:561. 
18   Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation 
of dose distributions. Med Phys. 1998;25:656–61.
A dose difference of 6% exists between the Monte Carlo and treatment 
planning dose contours for both sources. 
The NOD data were extracted from the data related to red channel of 
scanned RGB images. The following equation was fitted to the data for the 
dose and NOD:   
D D -0.1834 00996 . 0 0.8176e - e 0.8859 NOD =     (1)
The R
2 value for this fitting was equal to 0.9988.
The dose distributions in the plane parallel to the long axis of the GZP6 
source No. 2 presented by the GZP6 planning system and the Monte Carlo 
simulation are illustrated in Figure 5. The dose contours correspond to the 
dose values of 1.25-7.5 Gy.
One dimensional gamma index values related to the data in the transverse 
plane are plotted in Fig. 6. These gamma data were used for the compari-
son between the MC and RCF dose distributions as well as GZP6 TPS and 
RCF dose distributions for GZP6 sources No. 2 and 5. Gamma indices of 
1 or less are considered a “pass” and gamma values exceeding the unity 
are considered a “fail” (18). Gamma calculations were performed with 5% 
dose/2 mm distance criterion.
As it is evident from Figure 6, gamma values are less than unity in almost 
most points. There are only some limited points in the high dose gradient 
region for the source No. 5, which have gamma values more than unity. 
The gamma data indicate that GZP6 TPS dose data are validated for the 
source No. 2. However, isodose contours in the longitudinal plane for 
source No. 5 (Figure 5) indicate that the agreement becomes less for the 
source No. 5 since dose differences of up to 16% are observed between 
the isodose lines. 
Table 1. Air kerma strength values (µGym
2h
-1) for the GZP6 source No. 5 obtained 
by Monte Carlo, measurement and GZP6 TPS. 
MC Measurement GZP6 TPS
Air kerma strength 26885.81 26365.08 19279
As it is evident from Table 1, there is a good agreement between the 
Monte Carlo and measured value of air kerma strength (difference: 
1.98%) but a major discrepancy is observed between the Monte Carlo and 
GZP6 treatment planning system value of air kerma strength (difference: 
28.29%). Based on the aforementioned points, the value of Monte Carlo 
calculated air kerma strength was validated. Since the activity ascertained 
by the GZP6 manufacture was used in our Monte Carlo calculations of 
air kerma strength for the source No. 5, thus the corresponded value 
of activity ascertained by the GZP6 manufacturer for this source braid 
is verified. It could also be concluded that the discrepancy between the 
Monte Carlo calculated and measured dose distributions for the source 
braid No. 5 (Figure 5) was not originated from the activity of the source. 
When considering that the source No. 5 consists of three cobalt-60 pellets 
and observing that the dose discrepancy is more considered in the points 
outside the transverse plane (Figure 5), the discrepancy could be related 
to the uncertainty of each active pellet in the source, not the sum (total) 
activity that was validated here. So having more information about the 
accurate activity in each active pellet in this source braid can illuminate 
the cause of the discrepancies. Since the source braid is packed, direct 
measurement of activity of each pellet separately was not feasible. As it 
is mentioned in the methods section, a small experiment was performed 
by placing a sheet of Gafchromic EBT film under the source No. 5 for 
quantification of activity of the pellets in the source braid. The result of 
the experiment is plotted in Figure 7.
Figure 5. Isodose curves in the longitudinal plane for the GZP6 sources: (a) and (c) are related to Monte Carlo (color 
lines) versus RCF (blue lines). While (b) and (d) are related to RCF measurements (blue lines) versus GZP6 treatment 
planning system (color lines). Parts (a) and (b) are related to the source No two while parts (c) and (d) are related to 
the source No 5. Dose contours of 1.25-7.5 Gy are illustrated in the figure
Figure 6. The gamma values related to the transverse dose data used for comparison of MC and GZP6 TPS dose 
distributions with RCF data: (a) MC versus RCF for source No. 2; (b) GZP6 TPS versus RCF for source No. 2; (c) MC 
versus RCF for source No. 5; (d) GZP6 TPS versus RCF for source No. 56 7
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Figure 7. Dose map under the GZP6 source No. 5 to quantify the activity of each 
active pellet in this source braid
The details are not mentioned here but our results of the radiochromic 
film dosimetry under the source No. 5 showed that the sensitivity and 
accuracy of the experiment was not enough to accurately determine the 
activity of the active pellets in source No. 5.
CONCLUSIONS
The dose distribution in the transverse and longitudinal planes relative 
to the GZP6 source No. two and five when loaded in the GZP6 straight 
tandem applicator presented by the GZP6 treatment planning system was 
verified through Monte Carlo simulations and radiochromic film mea-
surements. Our results show that there are acceptable dose difference 
between the Monte Carlo simulation, radiochromic film measurements, 
and the GZP6 treatment planning dose distributions for source No. two. 
However, the GZP6 treatment planning system presents a simplified dose 
distribution in the regions near the tip and base of the applicator in the 
longitudinal directions for both sources. It can be concluded that the 
GZP6 treatment planning system presents accurate dose distributions in 
both transverse and longitudinal directions from the applicator when is 
used with the source number 2 of the unit. Dose distributions certified 
by the GZP6 TPS for the source No. 5 are not validated thoroughly in all 
points and there are some discrepancies between the results by the three 
mentioned methods for this source. The results of air kerma strength 
and radiochromic film dosimetry for source No. 5 (Table 1 and Figure 
7) indicated that while the total activity for the source used in our Monte 
Carlo calculations was accurate, the main cause of discrepancy between 
dose distribution estimation by MC and RCF dosimetry and GZP6 TPS 
for source No. 5 might be the inaccuracy of activities of active pellets 
in source No. 5 that were certified by GZP6 manufacturer. Therefore, 
accurate knowledge of the activity of each active pellet in source No. 5 
can illuminate the cause of the discrepancies for this source dosimetry.
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GZP6 treatment planning system value of air kerma strength (difference: 
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by the GZP6 manufacture was used in our Monte Carlo calculations of 
air kerma strength for the source No. 5, thus the corresponded value 
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by placing a sheet of Gafchromic EBT film under the source No. 5 for 
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Figure 5. Isodose curves in the longitudinal plane for the GZP6 sources: (a) and (c) are related to Monte Carlo (color 
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